dalteparin has been researched along with alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SH; Stevenson, JL; Varki, A | 1 |
1 other study(ies) available for dalteparin and alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
Article | Year |
---|---|
Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity.
Topics: Animals; Anticoagulants; Cell Line, Tumor; Disaccharides; Factor Xa; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Kinetics; L-Selectin; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Oligosaccharides; P-Selectin; Polysaccharides; Protein Binding; Selectins; Sialyl Lewis X Antigen; Temperature; Thrombosis; Time Factors; Tinzaparin | 2005 |